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Abstract :   
An efficient and one pot reaction of fluorinated 1,3,4-Thiadiazole derivatives was synthesis by fluorinated  
aromatic carboxylic  with thiosemicabazide in the presence of phosphorus oxychloride as a catalyst under 
Microwave irradiation with silica supported. The synthesis compound was characterized by 1H NMR, IR, and 
mass spectroscopic techniques. The present approach offers the advantages such as short reaction time, 
simplicity of the workup procedure, low cost and mild reaction condition. 
Keywords:1,3,4-Thiadazole, thiosemicarbazide, Silica supported, Microwave irradiation 
Introduction :  
Heterocyclic compounds containing five member rings with nitrogen and sulfur commonly are building blocks, 
with a possessing large number of interesting biological activities. 1,3,4-thiadiazoles derivatives  are five-
member  with  exciting isomeric form of thiadiazoles [1,2]. The important of 1,3,4-thiadiazole is  due to its Central 
Nervous System (CNS) disorders diagnostic ability due the lipo-solubility of sulfur atom. Compounds containing 
a 1,3,4-thiadiazole template have received  significant attention in chemical, medicinal and pharmaceutical 
research as this structural scaffold is found in a variety of drugs. 1,3,4-thiadiazole and its derivatives are showing  
immense importance  in medicinal chemistry research due to  biological  activity as well as producing useful 
intermediates in several organic preparations [3-7]. 1,3,4-Thiadiazoles are heterocyclic scaffolds incorporated in 
many compounds presenting various pharmacological activities  such as antibacterial [8-9], anticonvulsant [10], 
anti-inflammatory [11-13], antimicrobial [14-17] , antiproliferative [18-20], antioxidant [21], antitubercular [22],  
antitumor [23],  anticancer [24-25],  antiviral [26]. Similarly, the diagnostic section exhibits a complete 
investigation of the isomeric form and the anticancer activity of biocaster 1,3,4-thiadiazoles due to therapeutic 
potential [27-30]. Also fluorinated 1, 3, 4-thiadiazole exhibits more potent antitumor inhibitory activity than 
doxorubicin [31]. 1,3,4-thiadiazole is central part in several marketed drugs such as acetazolamide, a  carbonic 
anhydrase inhibitor used in treatment of glaucoma or sulfamethizole an antibacterial agent. 
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Materials and Methods: 
General: All the chemical and reagents used were of analytical grade from Aldrich and used without further 
purification.   and the completion of reaction and purity of the synthesized compounds were checked by TLC 
(0.5 mm thickness) using silica gel-G coated Aluminum plates (Merck).Melting points of the compounds were 
determined in open capillary tube by digital melting point apparatus and were uncorrected. 
Synthesis of Fluorinated 1,3,4-thiadiazol-2-amine 3 (a-f) under microwave irradiation. 
The mixture of fluoro substituted aromatic carboxylic acid (0.01mole), thiosemicarbazide (0.01mole), Silica oxide 
and 5 ml of phosphorus oxychloride were added. The mixture was irradiated under microwave irradiation at 120 
0C for 15 min.  The completion of the reaction was monitored by TLC. After completion of the reaction the RBF 
was removed from the oven. The reaction mixture was poured on to crushed ice drop wise with continuous 
stirring, neutralized by saturated KOH. Then filter, dried and re-crystallized from ethanol. 
Results and Discussion 
Table .1. Physical data of synthesized compounds 3(a-f) under microwave irradiation 
Entry Compound Ar 
  
M.P.(0C) 
Reaction Time 
(min) 
 
Yield (%) 
 
1 3a 
F
F F
F
 
15 91 222 
2 3b 
F
F
 
15 90 216 
3 3c 
F
Cl  
15 88 236 
4 3d 
F
F
F
 
15 90 155 
5 3e 
F
 
15 90 165 
6 3f 
F  
15 88 236 
 
An efficient, simple and one pot procedure is reported for the synthesis of   fluorinated 1,3,4-Thiadiazole 
derivative with  silica-support in the presence of phosphorus oxychloride microwave radiation  technique. 1,3,4-
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Thiadiazole derivative are synthesized by fluorinated aromatic carboxylic acid under above  of mention 
condition. The formation of substituted   1,3,4-Thiadiazole derivative were confirmed by   recording their IR, 1H 
NMR, and mass  spectral data. The compound  5-(2,3,5,6-tetrafluorophenyl)-1,3,4-thiadiazol-2-amine (3a) does 
not shows absorption band at 1700 (carbonyl stretching) broad band at 815 (C-S-C) is present. It shows 
absorption band at 1095, 1417, 1603cm−1is for to C-F,  C=C, C=N, stretching   respectively.1H NMR of compound 
3a  showed broad singlet in the  region of 𝛿:8.02  which is due to  de-shielded  caused by the four fluorine 
proton, the singlet at 8.02  for the NH2 of thiadiazole. The mass spectrum of 3a showed a molecular ion peak at 
m/z  250  which is in agreement with the molecular formula C8H3F4N3S. The IR absorption band around 815 cm–
1 could be attributed to the –C–S–C functional group. IR spectrum of 3b showed absorption bands at 3369, 1443, 
1596, 1054 cm−1 indicating the presence of NH2, C=C, C=N, C-F groups respectively. 1HNMR spectrum peaks 
due to NH2 protons appeared at 𝛿:7.46. Peaks for three aromatic proton appeared between   7.20-8.12. Further, 
LC mass spectrum showed molecular ion peak at m/z 214 which is in conforming the Molecular Structure of 3b. 
Conclusions 
In conclusion, we have reported an efficient and one pot method for the synthesis of fluorinated 1,3,4-
Thiadiazole by using fluorinated aromatic acid and thiosemicarbazide in of presence phosphorus oxychloride of 
under microwave irradiation. This method offers several advantages, including the low of  cost, high yields, clean 
reactions, and short reaction time for the synthesis of one pot synthesis of 1,3,4-thiadiazole. These derivatives 
have been given a key to more modifications in pharmacophore replacements. 
Data Availability  
5-(2,4-Difluoro-phenyl)-[1,3,4]thiadiazol-2-ylamine  (3a) 
Yield 85 %  m.p.216∘C; IR spectrum, ν, cm-1:  682(C-S-C stretching ), 3369 (NH2 stretching.) ; 1443(C=C Ar 
stretching), 1596 (C=N stretching ),1054 (C-F stretching ),; 1H NMR spectrum, 𝛿, ppm :: 7.20 (s, 1H), 7.41(d, J=8.96, 
1H), 7.46(s, 2H), 8.12(d, J=8.96, 1H), (MS: m/z: 214 (M+H) +. 
5-(3-Chloro-2-fluoro-phenyl)-[1,3,4]thiadiazol-2-ylamine (3b) 
Yield 84 %, m.p.151∘C; IR spectrumcm-1: 703 (C-S-C stretching ), 3385 (NH2stretching.); 1487(C=C Ar stretching), 
1607 (C=N stretching ),1009 (C-F stretching ),; 1H NMR spectrum, 𝛿, ppm :  7.40 ( dd, J=7.96, 8.4, 1H) , 7.52(1H, 
d, J=7.96, 1H), 8.00(s,2H), 8.16(d, J=8.4, 1H). (MS: m/z: 230 (M+H)  
5-(2,3,5,6-Tetrafluoro-phenyl)-[1,3,4]thiadiazol-2-ylamine (3c) 
Yield  82 %, m.p. 222 ∘C; IR spectrum, ν, cm-1: 793 (C-S-C stretching ), 3313 (NH2 stretching.); 1413 (C=C Ar 
stretching), 1595 (C=N stretching ),1030 (C-F stretching ) ,; 1H NMR spectrum, 𝛿, ppm ::8.02 (s, 1H), 8.01 (s,1H). 
(MS: m/z: 250 (M+H) +. 
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